M, N., T, Y., T, K., & S, N. (2017). New prognostic biomarkers and therapeutic effect of bevacizumab for patients with non-small-cell lung cancer. Dove Medical Press.
Cita Chicago Style (17a ed.)M, Niki, Yokoi T, Kurata T, y Nomura S. New Prognostic Biomarkers and Therapeutic Effect of Bevacizumab for Patients with Non-small-cell Lung Cancer. Dove Medical Press, 2017.
Cita MLA (8a ed.)M, Niki, et al. New Prognostic Biomarkers and Therapeutic Effect of Bevacizumab for Patients with Non-small-cell Lung Cancer. Dove Medical Press, 2017.
Precaución: Estas citas no son 100% exactas.